Relationship between subjective experiences and psychopathological dimensions in schizophrenia

Australian and New Zealand Journal of Psychiatry

Volumn 44, Issue 10, 2010, Pages 952-957

  Kim, Jong Hoon ^a   Byun, Hee Jung ^b   Ann, Jun Hyung ^a   Lee, Jinyoung ^a  

^a Gachon University   (South Korea)

^b Seoul Children's Hospital   (South Korea)

Author keywords

Negative symptoms; Positive symptoms; Schizophrenia; Subjective psychopathology

Indexed keywords

BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HALOPERIDOL; RISPERIDONE;

ADULT; AGITATION; AKATHISIA; ARTICLE; CORRELATION COEFFICIENT; DELUSION; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; PERSONAL EXPERIENCE; POSITIVE SYNDROME; PSYCHOMOTOR RETARDATION; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 77957975246     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048674.2010.495940     Document Type: Article

References (55)

1. Schultze-Lutter F. Subjective symptoms of schizophrenia in research and the clinic: The basic symptom concept. Schizophr Bull 2009; 35:5-8.
2. Klosterkötter J, Schultze-Lutter F, Ruhrmann S. Kraepelin and psychotic prodromal conditions. Eur Arch Psychiatry Clin Neurosci 2008; 258:S74 - 84.
3. Schultze-Lutter F, Ruhrmann S, Picker H, von Reventlow HG, Brockhaus-Dumke A, Klosterkötter J. Basic symptoms in early psychotic and depressive disorders. Br J Psychiatry 2007; 51:S31- 37.
4. Gross G. The ' basic ' symptoms of schizophrenia. Br J Psychiatry 1989; 7:S21 - 25.
5. Huber G, Gross G. The concept of basic symptoms in schizophrenic and schizoaffective psychoses. Recent Prog Med 1989; 80: 646-652.
6. Raballo A, Parnas J. The silent side of the spectrum: Schizotypy and the schizotaxic self. Schizophr Bull 2010 (In Press).
7. Vollmer-Larsen A, Handest P, Parnas J. Reliability of measuring anomalous experience: The Bonn Scale for the Assessment of Basic Symptoms. Psychopathology 2007; 40:345-348.
8. Parnas J, Handest P, Jansson L, Saebye D. Anomalous subjective experience among first-admitted schizophrenia spectrum patients: Empirical investigation. Psychopathology 2005; 38:259-267.
9. Parnas J, Handest P. Phenomenology of anomalous self-experience in early schizophrenia. Compr Psychiatry 2003; 44:121-134.
10. Süllwold L. Frankfurter Beschwerde-Fragebogen (3). In: Süllwold L, Huber G, eds. Schizophrene Basisstörungen (Basic Disturbance of Schizophrenia). Berlin: Springer, 1986:145-159.
11. Yon V, Loas G, Monestès JL. Relationships between schizotypy and subjective experiences in a sample of 399 university students. Compr Psychiatry 2009; 50:142-150
12. Yon V, Loas G, Brien D. Subjective experiences and the psychopathological dimensions in schizophrenia. Psychiatry Res 2005; 137:93-102.
13. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58:158-164.
14. Nakaya M, Kusumoto K, Ohmori K. Subjective experiences of Japanese inpatients with chronic schizophrenia. J Nerv Ment Dis 2002; 190:80-85.
15. Parnas J, Handest P, Saebye D, Jansson L. Anomalies of subjective experience in schizophrenia and psychotic bipolar illness. Acta Psychiatr Scand 2003; 108:126-133.
16. Handest P, Parnas J. Clinical characteristics of first-admitted patients with ICD-10 schizotypal disorder. Br J Psychiatry Suppl 2005; 48:S49 - 54.
17. Klosterkötter J. The meaning of basic symptoms for the genesis of the schizophrenic nuclear syndrome. Jpn J Psychiatry Neurol 1992; 46:609-630. (Pubitemid 23017245)
18. Chapman LJ, Chapman JP. The search for symptoms predictive of schizophrenia. Schizophr Bull 1987; 13:497-503.
19. Koehler K, Sauer H. Huber ' s basic symptoms: Another approach to negative psychopathology in schizophrenia. Compr Psychiatry 1984; 25:174-182.
20. Peralta V, Cuesta MJ. Subjective experiences in psychotic disorders: Diagnostic value and clinical correlates. Compr Psychiatry 1998; 39:11-15.
21. Van den Bosch RJ, Rombouts RP, Van Asma MJO. Subjective cognitive dysfunction in schizophrenic and depressed patients. Compr Psychiatry 1993; 34:130-136.
22. Jaeger J, Bitter I, Czobor P, Volavka J. The measurement of subjective experience in schizophrenia: The Subjective Deficit Syndrome Scale. Compr Psychiatry 1990; 31:216-226.
23. Liddle PF, Barnes TRE. The subjective experience of defi cits in schizophrenia. Compr Psychiatry 1988; 29:157-164.
24. Moritz S, Krausz M, Gottwalz E, Andresen B. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms. Compr Psychiatry 2000; 41:284-288.
25. Stanghellini G, Quercioli L, Ricca V, Strik WK, Cabras P. Basic symptoms and negative symptoms in the light of language impairment. Compr Psychiatry 1991; 32:141-146.
26. Kim JH, Kim SY, Byun HJ. Subjective cognitive dysfunction associated with drug-induced Parkinsonism in schizophrenia. Parkinsonism Relat Disord 2008; 14:239-242.
27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders , fourth edition. Washington, DC: American Psychiatric Association, 1994.
28. Meyer JM, Simpson GM. Anticholinergics and amantadine. In: Sadock BJ, Sadock VA, eds. Comprehensive textbook of psychiatry, seventh edition. Philadelphia: Lippincott Williams & Wilkins, 2000: 2276-2282.
29. Ballenger JC. Benzodiazepine receptor agonists and antagonists. In: Sadock BJ, Sadock VA, eds. Comprehensive textbook of psychiatry , seventh edition. Philadelphia: Lippincott Williams & Wilkins, 2000: 2317-2324
30. Chang HI, Kim JK, Yum TH et al. Manual of Kyung Hee Frankfurt Beschwerde Fragebogen. J Korean Neuropsychiatr Assoc 1995; 34:754-771.
31. Yon V, Loas G, Monestes JL. Dimensional structure of the Frankfurt Complaint Questionnaire in a sample of French students. Psychopathology 2008; 41:85-89.
32. Loas G, Yon V, Brien D. Dimensional structure of the Frankfurt Complaint Questionnaire. Compr Psychiatry 2002; 43: 397-403.
33. Cuesta MJ, Peralta V, Irigoyen I. Factor analysis of the Frankfurt Complaint Questionnaire in a Spanish sample. Psychopathology 1996; 29:46-53.
34. Cuesta MJ, Peralta V, Juan JA. Abnormal subjective experiences in schizophrenia: Its relationships with neuropsychological disturbances and frontal signs. Eur Arch Psychiatry Clin Neurosci 1996; 246:101-105.
35. Krawiecka M, Goldberg D, Vaughan M. A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 1977; 55:299-308.
36. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212:11-19.
37. Guy W. ECDEU assessment manual for psychopharmacology Washington, DC: Department of Health, Education and Welfare, 1976:76-338.
38. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154:672-676.
39. Kim JH, Jung HY, Kang UG et al Metric characteristics of the DIEPSS: A practical combined rating scale for drug-induced movement disorders. Mov Disord 2002; 17:1354-1359.
40. Kim JH, Cho SY, Byun HJ, Kang UG, Ahn YM, Kim YS. Multidimensional sensory phenomena in antipsychotic-induced akathisia. J Clin Psychopharmacol 2004; 24:618-623.
41. Prouteau A, Verdoux H, Briand C et al. Self-assessed cognitive dysfunction and objective performance in outpatients with schizophrenia participating in a rehabilitation program. Schizophr Res 2004; 69:85-91.
42. Hofer A, Rettenbacher MA, Widschwendter CG, Kemmler G, Hummer M, Fleischhacker WW. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. Eur Arch Psychiatry Clin Neurosci 2006; 256:246-255.
43. Naber D, Karow A. Good tolerability equals good results: The patient ' s perspective. Eur Neuropsychopharmacol 2001; 11:391-396.
44. Voruganti LN, Awad AG. Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia: Fi ndings from an in vivo SPECT study. Schizophr Res 2006; 88:179-186.
45. Lambert M, Naber D, Karow A et al. Subjective wellbeing under quetiapine treatment: Effect of diagnosis, mood state, and anxiety. Schizophr Res 2009; 110:72-79.
46. Yon V, Loas G. Relationships between subjective experiences of defi cit and other psychopathological features in schizophrenia. Psychopathology 2000; 33:110-114.
47. Iwawaki A, Narushima K, Ota K, Okura T, Tsuchiya K, Takashima A. Two factors of experienced defi cits in schizophrenia and their relationships with positive, negative, and depressive symptoms. Compr Psychiatry 1998; 39:386-391.
48. Peralta V, Cuesta MJ, de Leon J. Positive versus negative schizoph renia and basic symptoms. Compr Psychiatry 1992; 33:202-206.
49. Gross G, Huber G. Psychopathology of basic stages of schizophrenia in view of formal thought disturbances. Psychopathology 1985; 18: 115-125.
50. Peralta V, Cuesta MJ. Subjective experiences in schizophrenia: A critical review. Compr Psychiatry 1994; 35:198-204.
51. Simon AE, Dvorsky DN, Boesch J et al. Defining subjects at risk for psychosis: A comparison of two approaches. Schizophr Res 2006; 81:83-90.
52. Nelson B, Yung AR, Bechdolf A, McGorry PD. The phenomenological critique and self-disturbance: Implications for ultra-high risk ( ' prodrome ' ) research. Schizophr Bull 2008; 34:381-392.
53. Yung AR, Nelson B, Stanford C et al Validation of ' prodromal ' criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res 2008; 105:10-17.
54. Parnas J. Clinical detection of schizophrenia-prone individuals: Critical appraisal. Br J Psychiatry Suppl 2005; 48:S111 - 112.
55. Peralta V, Cuesta MJ. Motor features in psychotic disorders. I. Factor structure and clinical correlates. Schizophr Res 2001; 47:107-116.